The falling share price of Grand Pharmaceutical Group doesn'...
The falling share price of Grand Pharmaceutical Group doesn't align with its EPS growth. This suggests EPS may not truly reflect company performance or past growth expectations were too high.
As Grand Pharmaceutical Group (HKG:512) Lifts 3.4% This Past Week, Investors May Now Be Noticing the Company's Three-year Earnings Growth
免责声明：以上信息不代表Moomoo Technologies Inc.("MTI")的任何立场，不构成与MTI及其关联公司的任何投资建议。
更多信息
评论
登录发表评论
